Question 1

What is Howard L. Weiner?

Accepted Answer

Howard L. Weiner is a Person.

Question 2

How often does Howard L. Weiner appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was Howard L. Weiner first tracked by Ergen?

Accepted Answer

First tracked on Apr 01, 2026.

Question 4

When was Howard L. Weiner last mentioned in news?

Accepted Answer

Last active on May 28, 2026.

Question 5

What is Howard L. Weiner's current news sentiment?

Accepted Answer

Aggregate sentiment score: 25 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Howard L. Weiner in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Howard L. Weiner?

Accepted Answer

Tiziana Foralumab na-SPMS Clinical Data (May 19, 2026, 6 articles).

Question 8

How did the "Tiziana Foralumab na-SPMS Clinical Data" event impact Howard L. Weiner?

Accepted Answer

Howard L. Weiner, Director of the Ann Romney Center for Neurologic Diseases at Brigham and Women s Hospital and Chair of the Scientific Advisory Board of Tiziana Life Sciences, provided an encouraging statement supporting the potential of intranasal foralumab.

Question 9

How did the "Tiziana Life Sciences' Foralumab Preclinical Data" event impact Howard L. Weiner?

Accepted Answer

Howard L. Weiner is a co-corresponding author of the preclinical study and Chair of the Scientific Advisory Board of Tiziana Life Sciences, highlighting the significance of the findings and his involvement with the company.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.